Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Nahid, Payam ^a,b   Jarlsberg, Leah G ^a   Rudoy, Irina ^a,b   de Jong, Bouke C ^c   Unger, Alon ^d   Kawamura, L Masae ^a,b   Osmond, Dennis H ^a   Hopewell, Philip C ^a,b   Daley, Charles L ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Public Health   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; RISK FACTOR; SPUTUM SMEAR; SURVIVAL RATE; TREATMENT DURATION; ADOLESCENT; AGED; IMMUNOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SAN FRANCISCO; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 78650719424     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-1     Document Type: Article

References (16)

1. World Health Organization Report - Global Tuberculosis Control: Surveillance, Planning, Financing. 2009, Geneva, Switzerland.
2. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002, 34(6):752-759. 10.1086/338784, 11850859.
3. Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis 2006, 10(5):542-549.
4. Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J 2008, 31(6):1256-1260. 10.1183/09031936.00131107, 18515556.
5. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 1998, 114(5):1244-1252. 10.1378/chest.114.5.1244, 9823996.
6. Amnuaiphon W, Anuwatnonthakate A, Nuyongphak P, Sinthuwatanawibool C, Rujiwongsakorn S, Nakara P, Komsakorn S, Wattanaamornkiet W, Moolphate S, Chiengsorn N, et al. Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006. Trop Med Int Health 2009, 14(11):1338-1346. 10.1111/j.1365-3156.2009.02376.x, 19735372.
7. Koenig SP, Riviere C, Leger P, Joseph P, Severe P, Parker K, Collins S, Lee E, Pape JW, Fitzgerald DW. High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis 2009, 48(6):829-831. 10.1086/597098, 3010922, 19207078.
8. Horne DJ, Hubbard R, Narita M, Exarchos A, Park DR, Goss CH. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis 10:258. 10.1186/1471-2334-10-258, 2936899, 20799975.
9. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003, 167(4):603-662. 10.1164/rccm.167.4.603, 12588714.
10. Korenromp EL, Bierrenbach AL, Williams BG, Dye C. The measurement and estimation of tuberculosis mortality. Int J Tuberc Lung Dis 2009, 13(3):283-303.
11. Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL. Treatment Outcomes of Patients with HIV and Tuberculosis. Am J Respir Crit Care Med 2007, 175(11):1199-1206. 10.1164/rccm.200509-1529OC, 1899273, 17290042.
12. Rubin DB. Inference and missing data. Biometrika 1976, 63(3):581-592.
13. Cain KP, Anekthananon T, Burapat C, Akksilp S, Mankhatitham W, Srinak C, Nateniyom S, Sattayawuthipong W, Tasaneeyapan T, Varma JK. Causes of death in HIV-infected persons who have tuberculosis, Thailand. Emerg Infect Dis 2009, 15(2):258-264. 10.3201/eid1502.080942, 2657626, 19193270.
14. Low S, Ang LW, Cutter J, James L, Chee CB, Wang YT, Chew SK. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis 2009, 13(3):328-334.
15. Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Mei J. Deaths among tuberculosis cases in Shanghai, China: who is at risk?. BMC Infect Dis 2009, 9:95. 10.1186/1471-2334-9-95, 2702371, 19531267.
16. Mitchison DA. [Mechanisms of the action of drugs in the short-course chemotherapy]. Bull Int Union Tuberc 1985, 60(1-2):36-40.